Related Experiment Video
Updated: Jun 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Cell cycle inhibitor p21/ WAF1/ CIP1 as a cofactor of MITF expression in melanoma cells
Blanka Sestáková1, Lubica Ondrusová, Jiri Vachtenheim
1Laboratory of Molecular Biology, University Hospital, Charles University, Prague, Czech Republic.
Abstract:
p21/ WAF1/ Cip1 (p21), a cyclin-dependent kinase inhibitor, may act as an antioncogene, but may also behave as a tumor promoting factor by inhibiting apoptosis. p21 is also a transcriptional regulator, exerting this activity independently of cyclin-dependent kinases. Increased p21 protein levels were found in a subset of melanomas. However, the mechanism(s) contributing to the tolerance of high p21 levels in melanoma cells remains unexplained. Here, we show that the p21 protein positively regulates the promoter of microphthalmia-associated transcription factor (MITF), a transcription factor which plays a central role in the expression of melanocyte-specific genes, lineage determination, and survival of melanoma cells. p21 activated the MITF promoter-reporter, occupied the promoter in vivo and cooperated with cAMP response element binding protein (CREB) in promoter activation. In addition, p21 knockdown by shRNA resulted in a decrease of MITF protein and promoter activity, and p21 protein levels correlated with MITF mRNA in most cell lines tested. As the p21 gene is a known transcriptional target of MITF, the reciprocal stimulation of transcription may constitute a positive-feedback loop reinforcing MITF expression in melanoma cells. Our results might help explain the tolerance of increased p21 levels found in some melanomas.
Insights
The p21 protein boosts microphthalmia-associated transcription factor (MITF) in melanoma, potentially explaining high p21 levels. This discovery reveals a positive feedback loop crucial for melanoma cell survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- p21/WAF1/Cip1 (p21) is a cyclin-dependent kinase inhibitor with dual roles in cancer, potentially acting as an antioncogene or tumor promoter.
- Elevated p21 protein levels are observed in some melanomas, but the underlying mechanisms remain unclear.
- Microphthalmia-associated transcription factor (MITF) is critical for melanocyte development and melanoma cell survival.
Purpose of the Study:
- To investigate the regulatory relationship between p21 and MITF in melanoma cells.
- To elucidate the mechanism by which high p21 levels are tolerated in melanoma.
- To explore the potential for a positive feedback loop between p21 and MITF.
Main Methods:
- Reporter assays to assess MITF promoter activity.
- In vivo promoter occupancy studies.
- Knockdown of p21 using short hairpin RNA (shRNA).
- Correlation analysis of p21 protein and MITF mRNA levels across cell lines.
Main Results:
- p21 directly activates the MITF promoter and binds to it in vivo.
- p21 cooperates with CREB (cAMP response element binding protein) to enhance MITF promoter activity.
- p21 knockdown leads to reduced MITF protein levels and promoter activity.
- p21 protein levels positively correlate with MITF mRNA levels in most tested melanoma cell lines.
Conclusions:
- p21 positively regulates MITF transcription in melanoma cells.
- A reciprocal transcriptional feedback loop exists between p21 and MITF, reinforcing MITF expression.
- This feedback loop may explain the tolerance of high p21 levels in certain melanomas.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Mitogens and the Cell Cycle
Mitogens and the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules

